High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients

BACKGROUND: Considering the recent advancements in the treatment of breast cancer with low expression of human epidermal growth factor receptor 2 (HER2), we aimed to examine inter-laboratory variability in the assessment of HER2-low breast cancer across all Danish pathology departments. METHODS: Fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Kåre, Sode, Michael, Jensen, Maj-Britt, Berg, Tobias, Knoop, Ann, Ejlertsen, Bent, Lænkholm, Anne-Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636935/
https://www.ncbi.nlm.nih.gov/pubmed/37946261
http://dx.doi.org/10.1186/s13058-023-01739-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636935/
https://www.ncbi.nlm.nih.gov/pubmed/37946261
http://dx.doi.org/10.1186/s13058-023-01739-9

Ejemplares similares